Eton Pharmaceuticals Inc
Buy or Sell?
I guess you are interested in Eton Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
Let's start. I'm going to help you getting a better view of Eton Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
- Company's Financial Health
A deep dive into the books. How are the numbers doing? Is Eton Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend. - Market Valuation
Finally, you now have an insight of how Eton Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Eton Pharmaceuticals Inc. The closing price on 2022-08-08 was $2.98 per share. Is the company over- or underpriced? - Key Performance Indicators
A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
1.1. Profitability of Eton Pharmaceuticals Inc.
An important factor of a company's health is the profitability.
1.1.1. Net Profit Margin of Eton Pharmaceuticals Inc.
One of the most important indicator to determine the financial health of a company is the Net Profit Margin. What is the net profit from the generated revenue? A healthy Net Profit Margin is higher than 10%.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | -244.9% | -295.7% | -17,093.1% |
| TTM | -279.0% | -308.5% | -2,439,802.1% |
| YOY | -7,264.3% | -355.4% | -649,607.8% |
| 5Y | -2,299.1% | -497.9% | -888,032.3% |
| 10Y | -2,299.1% | -546.1% | -787,669.6% |
Let's take a look of the Net Profit Margin trends of Eton Pharmaceuticals Inc:
- The MRQ is -244.9%. The company is losing money. -2
- The TTM is -279.0%. The company is losing money. -2
- The TTM is -279.0%. Compared to the MRQ, the short term is trending up. +1
- The YOY is -7,264.3%. Compared to the TTM, the mid term is trending up. +1
- The 5Y is -2,299.1%. Compared to the TTM, the 5Y term is trending up. +1
- The 10Y is -2,299.1%. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Net Profit Margin with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -295.7%. The company's MRQ (-244.9%) is outperforming the industry with 50.8%. +1
- The TTM average (mean) in the Biotechnology industry is -308.5%. The company's TTM (-279.0%) is outperforming the industry with 29.5%. +1
1.1.2. Return On Assets of Eton Pharmaceuticals Inc.
A healthy Return On Assets is above 5%.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | -23.0% | -10.0% | -103,584.9% |
| TTM | -10.4% | -8.6% | -34,417.1% |
| YOY | -25.6% | -9.6% | -2,259.2% |
| 5Y | -26.0% | -11.5% | -15,364.0% |
| 10Y | -26.0% | -12.4% | -14,625.0% |
Let's take a look of the Return On Assets trends of Eton Pharmaceuticals Inc:
- The MRQ is -23.0%. Very bad. -2
- The TTM is -10.4%. Very bad. -2
- The TTM is -10.4%. Compared to the MRQ, the short term is trending down. -1
- The YOY is -25.6%. Compared to the TTM, the mid term is trending up. +1
- The 5Y is -26.0%. Compared to the TTM, the 5Y term is trending up. +1
- The 10Y is -26.0%. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Return On Assets with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -10.0%. The company's MRQ (-23.0%) is underperforming the industry with -13.0%. -1
- The TTM average (mean) in the Biotechnology industry is -8.6%. The company's TTM (-10.4%) is underperforming the industry with -1.8%. -1
1.1.3. Return On Equity of Eton Pharmaceuticals Inc.
A healthy Return On Equity is above 15%.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | -39.8% | -11.9% | -139,340.4% |
| TTM | -17.9% | -10.6% | -41,918.1% |
| YOY | -140.3% | -10.9% | -94.4% |
| 5Y | -51.2% | -13.2% | -12,694.2% |
| 10Y | -51.2% | -14.0% | -12,490.3% |
Let's take a look of the Return On Equity trends of Eton Pharmaceuticals Inc:
- The MRQ is -39.8%. Very bad. -2
- The TTM is -17.9%. Very bad. -2
- The TTM is -17.9%. Compared to the MRQ, the short term is trending down. -1
- The YOY is -140.3%. Compared to the TTM, the mid term is trending up. +1
- The 5Y is -51.2%. Compared to the TTM, the 5Y term is trending up. +1
- The 10Y is -51.2%. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Return On Equity with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -11.9%. The company's MRQ (-39.8%) is underperforming the industry with -27.9%. -1
- The TTM average (mean) in the Biotechnology industry is -10.6%. The company's TTM (-17.9%) is underperforming the industry with -7.3%. -1
1.2. Operating Efficiency of Eton Pharmaceuticals Inc.
1.2.1. Operating Margin of Eton Pharmaceuticals Inc.
A healthy Operating Margin is above 15%.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | -233.8% | -243.5% | -553,448.2% |
| TTM | -281.5% | -272.5% | -3,226,197.1% |
| YOY | -7,059.8% | -318.5% | -650,862.1% |
| 5Y | -2,245.9% | -465.9% | -1,311,843.8% |
| 10Y | -2,245.9% | -537.4% | -1,186,905.2% |
Let's take a look of the Operating Margin trends of Eton Pharmaceuticals Inc:
- The MRQ is -233.8%. Very bad. -2
- The TTM is -281.5%. Very bad. -2
- The TTM is -281.5%. Compared to the MRQ, the short term is trending up. +1
- The YOY is -7,059.8%. Compared to the TTM, the mid term is trending up. +1
- The 5Y is -2,245.9%. Compared to the TTM, the 5Y term is trending up. +1
- The 10Y is -2,245.9%. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Operating Margin with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -243.5%. The company's MRQ (-233.8%) is outperforming the industry with 9.7%. +1
- The TTM average (mean) in the Biotechnology industry is -272.5%. The company's TTM (-281.5%) is underperforming the industry with -9.0%. -1
1.2.2. Operating Ratio of Eton Pharmaceuticals Inc.
A healthy Operating Ratio is below 1.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | 3.338 | 2.906 | 64.990 |
| TTM | 3.705 | 3.381 | 26,100.078 |
| YOY | 70.774 | 3.473 | 6,473.727 |
| 5Y | 22.862 | 5.623 | 8,734.426 |
| 10Y | 22.862 | 6.453 | 7,758.063 |
Let's take a look of the Operating Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is 3.338. Very good. +2
- The TTM is 3.705. Very good. +2
- The TTM is 3.705. Compared to the MRQ, the short term is trending down. +1
- The YOY is 70.774. Compared to the TTM, the mid term is trending down. +1
- The 5Y is 22.862. Compared to the TTM, the 5Y term is trending down. +1
- The 10Y is 22.862. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Operating Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 2.906. The company's MRQ (3.338) is underperforming the industry with 0.432. -1
- The TTM average (mean) in the Biotechnology industry is 3.381. The company's TTM (3.705) is underperforming the industry with 0.324. -1
1.3. Liquidity of Eton Pharmaceuticals Inc.
1.3.1. Current Ratio of Eton Pharmaceuticals Inc.
A healthy Current Ratio is above 1.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | 5.385 | 5.492 | 9.776 |
| TTM | 6.187 | 6.412 | 10.557 |
| YOY | 5.924 | 5.770 | 9.689 |
| 5Y | 8.221 | 6.609 | 9.402 |
| 10Y | 8.221 | 6.367 | 12.667 |
Let's take a look of the Current Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is 5.385. Very Good. +2
- The TTM is 6.187. Very Good. +2
- The TTM is 6.187. Compared to the MRQ, the short term is trending down. -1
- The YOY is 5.924. Compared to the TTM, the mid term is trending up. +1
- The 5Y is 8.221. Compared to the TTM, the 5Y term is trending down. -1
- The 10Y is 8.221. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Current Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 5.492. The company's MRQ (5.385) is underperforming the industry with -0.107. -1
- The TTM average (mean) in the Biotechnology industry is 6.412. The company's TTM (6.187) is underperforming the industry with -0.225. -1
1.3.2. Quick Ratio of Eton Pharmaceuticals Inc.
A healthy Quick Ratio is above 1.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | 4.602 | 4.546 | 10.064 |
| TTM | 5.419 | 4.993 | 14.947 |
| YOY | 4.899 | 4.307 | 12.682 |
| 5Y | 5.486 | 4.923 | 3,967.071 |
| 10Y | 5.486 | 4.528 | 3,908.664 |
Let's take a look of the Quick Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is 4.602. Very good. +2
- The TTM is 5.419. Very good. +2
- The TTM is 5.419. Compared to the MRQ, the short term is trending down. -1
- The YOY is 4.899. Compared to the TTM, the mid term is trending up. +1
- The 5Y is 5.486. Compared to the TTM, the 5Y term is trending down. -1
- The 10Y is 5.486. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Quick Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 4.546. The company's MRQ (4.602) is outperforming the industry with 0.056. +1
- The TTM average (mean) in the Biotechnology industry is 4.993. The company's TTM (5.419) is outperforming the industry with 0.426. +1
1.4. Solvency of Eton Pharmaceuticals Inc.
1.4.1. Total-Debt-to-Total-Assets Ratio of Eton Pharmaceuticals Inc.
A healthy Total-Debt-to-Total-Assets Ratio is below 1.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | 0.423 | 0.259 | 3.659 |
| TTM | 0.375 | 0.268 | 2.547 |
| YOY | 0.527 | 0.326 | 20.602 |
| 5Y | 0.311 | 0.368 | 6.584 |
| 10Y | 0.311 | 0.397 | 6.306 |
Let's take a look of the Total-Debt-to-Total-Assets Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is 0.423. Very good. +2
- The TTM is 0.375. Very good. +2
- The TTM is 0.375. Compared to the MRQ, the short term is trending up. -1
- The YOY is 0.527. Compared to the TTM, the mid term is trending down. +1
- The 5Y is 0.311. Compared to the TTM, the 5Y term is trending up. -1
- The 10Y is 0.311. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Total-Debt-to-Total-Assets Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 0.259. The company's MRQ (0.423) is underperforming the industry with 0.164. -1
- The TTM average (mean) in the Biotechnology industry is 0.268. The company's TTM (0.375) is underperforming the industry with 0.107. -1
1.4.2. Debt-To-Equity Ratio of Eton Pharmaceuticals Inc.
A healthy Debt-To-Equity Ratio is below 2.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | 0.733 | 0.295 | 1.450 |
| TTM | 0.608 | 0.302 | 2.112 |
| YOY | 2.352 | 0.333 | 1.385 |
| 5Y | 0.758 | 0.383 | 3.941 |
| 10Y | 0.758 | 0.432 | 4.770 |
Let's take a look of the Debt-To-Equity Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is 0.733. Very good. +2
- The TTM is 0.608. Very good. +2
- The TTM is 0.608. Compared to the MRQ, the short term is trending up. -1
- The YOY is 2.352. Compared to the TTM, the mid term is trending down. +1
- The 5Y is 0.758. Compared to the TTM, the 5Y term is trending down. +1
- The 10Y is 0.758. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Debt-To-Equity Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 0.295. The company's MRQ (0.733) is underperforming the industry with 0.438. -1
- The TTM average (mean) in the Biotechnology industry is 0.302. The company's TTM (0.608) is underperforming the industry with 0.306. -1
2. Market Valuation of Eton Pharmaceuticals Inc.
2.1. Price-to-Earnings Ratio of Eton Pharmaceuticals Inc.
A Price-to-Earnings Ratio above 15 may indicate an overpriced stock. However this is very hard to determine. Best way is to compare the PE Ratio with the industry average.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| EOD | -6.061 | -2.658 | -229.719 |
| MRQ | -8.867 | -3.272 | -13.921 |
| TTM | -20.119 | -4.408 | -38.909 |
| YOY | -7.106 | -4.640 | -52.545 |
| 5Y | -7.111 | -3.835 | -35.810 |
| 10Y | -7.111 | -3.316 | -30.662 |
Let's take a look of the Price-to-Earnings Ratio trends of Eton Pharmaceuticals Inc:
- The EOD is -6.061. Company is losing money. -2
- The MRQ is -8.867. Company is losing money. -2
- The TTM is -20.119. Company is losing money. -2
- The TTM is -20.119. Compared to the MRQ, the short term is trending up. -1
- The YOY is -7.106. Compared to the TTM, the mid term is trending down. +1
- The 5Y is -7.111. Compared to the TTM, the 5Y term is trending down. +1
- The 10Y is -7.111. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Price-to-Earnings Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -3.272. The company's MRQ (-8.867) is outperforming the industry with -5.595. +1
- The TTM average (mean) in the Biotechnology industry is -4.408. The company's TTM (-20.119) is outperforming the industry with -15.711. +1
2.2. Price/Earnings-to-Growth Ratio of Eton Pharmaceuticals Inc.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| MRQ | -11.979 | -3.284 | -4,447.379 |
| TTM | -203.306 | -5.652 | -3,498.411 |
| YOY | -13.303 | -6.383 | -66.215 |
| 5Y | -82.262 | -7.557 | -5,757.755 |
| 10Y | -82.262 | -7.614 | -7,628.574 |
Let's take a look of the Price/Earnings-to-Growth Ratio trends of Eton Pharmaceuticals Inc:
- The MRQ is -11.979. Very Bad. -2
- The TTM is -203.306. Very Bad. -2
- The TTM is -203.306. Compared to the MRQ, the short term is trending up. -1
- The YOY is -13.303. Compared to the TTM, the mid term is trending down. +1
- The 5Y is -82.262. Compared to the TTM, the 5Y term is trending down. +1
- The 10Y is -82.262. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Price/Earnings-to-Growth Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is -3.284. The company's MRQ (-11.979) is outperforming the industry with -8.695. +1
- The TTM average (mean) in the Biotechnology industry is -5.652. The company's TTM (-203.306) is outperforming the industry with -197.654. +1
2.3. Price-to-Book Ratio of Eton Pharmaceuticals Inc.
A healthy Price-to-Book Ratio is below 3.
| Period | Eton Pharmaceuticals Inc | Biotechnology (mean) | Biotechnology (average) |
|---|---|---|---|
| EOD | 5.634 | 2.174 | 80.241 |
| MRQ | 8.243 | 2.619 | 28.394 |
| TTM | 7.546 | 3.214 | 47.206 |
| YOY | 39.369 | 3.506 | 50.058 |
| 5Y | 13.023 | 2.896 | 713.476 |
| 10Y | 13.023 | 2.529 | 469.220 |
Let's take a look of the Price-to-Book Ratio trends of Eton Pharmaceuticals Inc:
- The EOD is 5.634. Seems overpriced? -1
- The MRQ is 8.243. Seems overpriced? -1
- The TTM is 7.546. Seems overpriced? -1
- The TTM is 7.546. Compared to the MRQ, the short term is trending up. -1
- The YOY is 39.369. Compared to the TTM, the mid term is trending down. +1
- The 5Y is 13.023. Compared to the TTM, the 5Y term is trending down. +1
- The 10Y is 13.023. Compared to the 5Y term, the 10Y term is not trending.
Let's compare the company's Price-to-Book Ratio with the average (mean) in the Biotechnology industry:
- The MRQ average (mean) in the Biotechnology industry is 2.619. The company's MRQ (8.243) is underperforming the industry with 5.624. -1
- The TTM average (mean) in the Biotechnology industry is 3.214. The company's TTM (7.546) is underperforming the industry with 4.332. -1
2.4. Latest News of Eton Pharmaceuticals Inc
Does Eton Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Eton Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.
| Date | Title | Read |
|---|---|---|
| 2022-08-08 16:00 | Analysts Estimate Fortress Biotech (FBIO) to Report a Decline in Earnings: What to Look Out for | Read |
| 2022-08-04 16:00 | Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: Should You Buy? | Read |
3. Holders & Insider Transactions
Let's take a look at which institutions, funds and insiders are holding shares of Eton Pharmaceuticals Inc.
3.1. Institutions holding Eton Pharmaceuticals Inc
Institutions are holding 24.024% of the shares of Eton Pharmaceuticals Inc.
| Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
|---|---|---|---|---|---|---|
| 2022-03-31 | Opaleye Management Inc | 9.4324 | 3.2218 | 2379275 | -5725 | -0.24 |
| 2022-03-31 | Vanguard Group Inc | 3.4604 | 0.0001 | 872871 | -5531 | -0.6297 |
| 2022-03-31 | Awm Investment Company Inc | 1.8735 | 0.2652 | 472588 | -27412 | -5.4824 |
| 2022-03-31 | Roumell Asset Management, LLC | 1.7818 | 3.1668 | 449438 | 0 | 0 |
| 2021-12-31 | BlackRock Inc | 1.1851 | 0 | 298942 | -1955 | -0.6497 |
| 2022-03-31 | Westside Investment Management, Inc. | 0.9603 | 0.0071 | 242220 | 123695 | 104.3619 |
| 2022-03-31 | Bridgeway Capital Management, LLC | 0.8926 | 0.019 | 225163 | 21900 | 10.7742 |
| 2022-03-31 | Geode Capital Management, LLC | 0.7412 | 0.0001 | 186971 | 11118 | 6.3223 |
| 2022-03-31 | First Citizens Bank & Trust Co | 0.3964 | 0.0169 | 100000 | 100000 | 0 |
| 2022-03-31 | Paradigm Capital Management, Inc. | 0.3964 | 0.0236 | 100000 | 10000 | 11.1111 |
| 2022-03-31 | State Street Corporation | 0.3632 | 0 | 91603 | 7831 | 9.348 |
| 2022-03-31 | Bank of New York Mellon Corp | 0.315 | 0.0001 | 79455 | 0 | 0 |
| 2022-03-31 | Blair William & Co | 0.1543 | 0.0006 | 38932 | -5068 | -11.5182 |
| 2022-03-31 | Northern Trust Corp | 0.1203 | 0 | 30355 | 0 | 0 |
| 2022-03-31 | Morgan Stanley - Brokerage Accounts | 0.1113 | 0 | 28071 | -2001 | -6.654 |
| 2022-03-31 | Group One Trading, LP | 0.1043 | 0.0001 | 26319 | -12481 | -32.1675 |
| 2022-03-31 | GSA Capital Partners LLP | 0.097 | 0.0144 | 24475 | -15342 | -38.5313 |
| 2022-03-31 | JPMorgan Chase & Co | 0.0962 | 0 | 24273 | 24273 | 0 |
| 2022-03-31 | PDT Partners, LLC | 0.0928 | 0.0088 | 23420 | 23420 | 0 |
| 2022-03-31 | Susquehanna Fundamental Investments, LLC | 0.0843 | 0.0018 | 21269 | -7292 | -25.5313 |
| Total | 22.6588 | 6.7464 | 5715640 |
3.2. Funds holding Eton Pharmaceuticals Inc
| Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
|---|---|---|---|---|---|---|
| 2022-05-31 | Vanguard Total Stock Mkt Idx Inv | 2.2807 | 0.0001 | 575285 | 0 | 0 |
| 2022-05-31 | Roumell Opportunistic Value Instl | 1.7818 | 1.4851 | 449438 | 0 | 0 |
| 2022-05-31 | Vanguard Extended Market Index Investor | 1.0276 | 0.0009 | 259195 | 0 | 0 |
| 2022-06-30 | Paradigm Micro-Cap | 0.7929 | 0.5043 | 200000 | 100000 | 100 |
| 2022-03-31 | Bridgeway Ultra-Small Company | 0.6944 | 0.8443 | 175163 | 60300 | 52.4973 |
| 2022-05-31 | Fidelity® Extended Market Index | 0.377 | 0.0009 | 95094 | 0 | 0 |
| 2022-05-31 | Vifag 2002 SICAV | 0.3568 | 0.5274 | 90000 | 0 | 0 |
| 2022-03-31 | Bridgeway Ultra-Small Company Market | 0.1982 | 0.0912 | 50000 | -38400 | -43.4389 |
| 2022-06-30 | iShares Micro-Cap ETF | 0.1677 | 0.0127 | 42312 | 0 | 0 |
| 2022-05-31 | Fidelity® Total Market Index | 0.1206 | 0.0001 | 30410 | 0 | 0 |
| 2022-06-30 | BlackRock Extended Equity Market K | 0.1151 | 0.0007 | 29035 | 53 | 0.1829 |
| 2022-05-31 | Fidelity® Series Total Market Index | 0.108 | 0.0002 | 27239 | 0 | 0 |
| 2022-05-31 | Fidelity® NASDAQ Composite Index® | 0.0768 | 0.0005 | 19371 | 0 | 0 |
| 2022-05-31 | Vanguard Instl Ttl Stk Mkt Idx InstlPls | 0.0614 | 0.0002 | 15500 | 0 | 0 |
| 2022-03-31 | AJO Vista US Micro Cap Equity | 0.059 | 0.3659 | 14892 | 14892 | 0 |
| 2022-03-31 | Northern Trust Extended Eq Market Idx | 0.0582 | 0.0012 | 14685 | 0 | 0 |
| 2022-03-31 | NT Ext Equity Mkt Idx Fd - L | 0.0582 | 0.0012 | 14685 | 0 | 0 |
| 2022-05-31 | Vanguard Balanced Index Inv | 0.0551 | 0.0001 | 13900 | 0 | 0 |
| 2022-03-31 | NT Ext Equity Mkt Idx Fd - NL | 0.0541 | 0.0009 | 13655 | 0 | 0 |
| 2022-05-31 | Spartan Total Market Index Pool E | 0.0507 | 0.0002 | 12790 | 0 | 0 |
| Total | 8.4943 | 3.8381 | 2142649 |